Introduction
Cyclin-dependent kinases (CDKs) are a family of enzymes that initiate and coordinate cell cycle progression. The CDK alone is inactive and requires both association with a regulatory subunit and activating phosphorylation on a conserved residue (Thr160 in human CDK2) located on the 'T-loop' of the kinase to be fully active (for a review, see Morgan, 1997) . In inactive, monomeric CDK molecules, the T-loop blocks the catalytic site, preventing substrate binding (De Bondt et al., 1993) . The binding of the cyclin realigns the PSTAIRE motif helix but also moves the T-loop down towards the C-terminal lobe (Jeffrey et al., 1995; Russo et al., 1996) . The Thr160 phosphorylation contributes to the activation process by stabilizing the T-loop in an active conformation through interactions of the phosphorylated threonine with several cationic residues (Russo et al., 1996) .
The CDK-activating kinase or CAK was first described as a biochemically purified activity from vertebrate and 7230 © European Molecular Biology Organization invertebrate sources (Desai et al., 1992; Solomon et al., 1992) . Subsequently, the p40 MO15 serine-threonine kinase (Shuttleworth et al., 1990) was identified as the catalytic activity in CAK (Fesquet et al., 1993; Poon et al., 1993; Solomon et al., 1993) . p40 MO15 was found to function in complex with cyclin H (Fisher and Morgan, 1994; Mäkelä et al., 1994) and assembly factor MAT1 (Devault et al., 1995; Fisher et al., 1995; Tassan et al., 1995) and was renamed CDK7. MAT1 has now also been implicated in substrate recognition (Inamoto et al., 1997; Ko et al., 1997; Rossignol et al., 1997; Yankulov and Bentley, 1997 ).
The CDK7-cyclin H complex not only has CAK activity but is also part of the TFIIH transcription factor complex where it regulates the activity of RNA polymerase II by phosphorylation of the C-terminal domain (CTD) (Roy et al., 1994; Mäkelä et al., 1995; Serizawa et al., 1995; Shiekhattar et al., 1995) . Budding yeast Saccharomyces cerevisiae has a complex closely related to CDK7-cyclin H-MAT1 and consists of the kinase Kin28, cyclin Ccl1 and Tfb3/Rig2 (Simon et al., 1986; Valay et al., 1993; Faye et al., 1997; Feaver et al., 1997) . This complex was also identified as part of TFIIH (Feaver et al., 1994) and is a CTD kinase important for transcription of most RNA pol II transcripts (Valay et al., 1995; Hengartner et al., 1998; Lee and Lis, 1998; McNeil et al., 1998) . However, in contrast to the CDK7 complex, Kin28 is not a CAK (Cismowski et al., 1995; Valay et al., 1995) . Instead, the budding yeast has a distinct single subunit kinase Cak1/ Civ1 that activates Cdc28 (and possibly other CDKs) in vivo, and is unrelated to CDK7/Kin28 (Espinoza et al., 1996; Kaldis et al., 1996; Thuret et al., 1996) .
The appearance of the CDK7-cyclin H-MAT1 in TFIIH and the identification of Cak1/Civ1 raised the question of whether CDK7-cyclin H-MAT1 is an in vivo CAK. Two lines of experimentation recently have addressed this question. Using cycling Xenopus egg extracts, it was demonstrated that immunodepletion of CDK7 suppressed CAK activity and inhibited entry into M-phase . The CAK activity was restored by translation of CDK7 and its associated subunits, demonstrating that a CDK7 complex is necessary for activation of CDKcyclin complexes. Using both temperature-sensitive and null alleles of the Drosophila CDK7 gene, Larochelle et al. (1998) showed that CDK7 is necessary for CAK activity of cdc2-cyclin B and cdc2-cyclin A in vivo in a multicellular organism.
The homologue of CDK7-cyclin H in fission yeast Schizosaccharomyces pombe is Mcs6-Mcs2. This complex is similar to the CDK7 complex in that it has both CTD and CAK activities in vitro (Buck et al., 1995; Damagnez et al., 1995) . Both mcs2 and mcs6 were isolated originally as potential mitotic inducers in a screen for suppressors of 'mitotic catastrophe', or premature entry into mitosis resulting from elevated, unregulated cdc2 activity (Molz et al., 1989; Molz and Beach, 1993) . Moreover, the alleles isolated during the screen (mcs6-13 and mcs2-75) display allele-specific interactions with cdc2-3w, reminiscent of the range of interactions described between cdc2 and cdc13 (Booher and Beach, 1987; Molz et al., 1989 (Damagnez et al., 1995) . In these respects, the mammalian CDK7 and fission yeast Mcs6 appear to be structural and functional homologues, whereas the budding yeast Kin28 kinase is clearly distinct in both its inability to function as a CAK and its inability to replace Mcs6 (Buck et al., 1995) .
While Mcs6 and CDK7 are CAKs, they are also CDKs, and, indeed similarly to most CDKs, contain a potential activating phosphorylation site in the 'T-loop' (T170 in human CDK7; T176 in Xenopus CDK7; S165 in Mcs6). A second potential phosphorylation site on the T-loop is located close by on the N-terminal side (S164 in human CDK7; S170 in Xenopus CDK7; T160 in Mcs6). The functional significance of either of these sites has been questioned, as in the presence of MAT1 an unphosphorylated CDK7 can associate with cyclin H to form an active complex . On the other hand, both sites are phosphorylated in vivo (Labbe et al., 1994) . In addition, in the absence of MAT1, CDK7 requires T170 (or T176 in Xenopus) phosphorylation for cyclin H binding (Fisher and Morgan, 1994; Mäkelä et al., 1994) and full activity (Labbe et al., 1994; Martinez et al., 1997; our unpublished results) , and indeed biochemical purification of CDK7 complexes from cells has revealed dimeric complexes not containing MAT1 (Devault et al., 1995) .
The kinase responsible for the activating phosphorylation of the CDK7 CAK (CAK-activating kinase or CAKAK) has not been identified in vivo. Although both CDK2-cyclin A and cdc2-cyclin B readily catalyse dual phosphorylation of CDK7 T-loop in vitro Martinez et al., 1997) , the CDK7 phosphorylation and activation does not correlate well with CDK2-or cdc2-associated kinase activity (Martinez et al., 1997) , suggesting the existence of other CAKAK(s).
Here the S.pombe Csk1 kinase is identified as an in vivo activating kinase of the Mcs6-Mcs2 CAK. The csk1 gene was isolated as a multicopy suppressor of the synthetic lethality of a mcs2-75 cdc2-3w cdc25-22 triple mutant strain (used to clone mcs2; Molz and Beach, 1993) . csk1 displayed a specific genetic interaction with mcs2, but unlike mcs2 is not as essential gene. Here this genetic interaction is extended to reflect a functional in vivo interaction of csk1, mcs2 and mcs6.
Results
Synthetic lethality of mcs6-13 when combined with csk1::sup3-5 As csk1 has been isolated as an efficient suppressor of the mcs2-75 allele (Molz and Beach, 1993) , it was interesting to study genetic interactions of csk1 with mcs6, which encodes for the CDK associated with the Mcs2 cyclin. For this purpose, a strain with a csk1 deletion (csk1::sup3-5; Molz and Beach, 1993 ) and a strain with the mcs6-13 (Molz et al., 1989 ) allele were used. The mcs6-13 allele has been isolated as an extragenic suppressor of the mitotic catastrophe phenotype caused by the combination of an activated allele of cdc2 (cdc2-3w) and a recessive temperature-sensitive wee1 mutation (wee1-50; Molz et al., 1989) .
When these strains were grown on rich medium plates at 30 or 37°C, the mcs6-13 conferred no phenotype, whereas the csk1::sup3-5 displayed a weak thermosensitive phenotype ( Figure 1A ). The same phenotype was observed in a strain with a URA4ϩ disruption of csk1 (data not shown). Combining mcs6-13 and csk1::sup3-5 led to a synthetic lethality on rich medium at 37°C ( Figure  1A ). To analyse the phenotype of the double mutant cells, they were grown in minimal media and stained with calcofluor and 4Ј,6-diamidino-2-phenylindole (DAPI) 20 h after a temperature shift ( Figure 1C ). The cells appeared highly elongated, with fragmented chromatin, multiple division septa and aberrant calcofluor staining of cell wall material at the ends of the cells. Overexpression of csk1 fully rescues the phenotype of the double mutant strain at 37°C ( Figure 1D ). These results indicate that there is a strong genetic interaction between csk1 and mcs6, as previously reported for csk1 and mcs2 (Molz and Beach, 1993) . The conditional phenotype of the mcs6-13 csk1::sup3-5 strain is somewhat reminiscent of those observed with spores harbouring either a mcs2 or a mcs6 deletion (Molz and Beach, 1993; Buck et al., 1995) .
During these studies, it was observed that the csk1 disruption (both the csk1::sup3-5 and a csk1::URA4ϩ strain) did not grow as well as a wild-type strain on minimal media, although no significant difference was observed on rich media. The poor growth was associated with the aberrant calcofluor staining observed in the synthetic lethal strain, but the other abnormalities of the synthetic lethal strain were not observed, as shown for csk1::URA4ϩ in Figure 1F . In addition, when stationary phase wild-type or csk1::URA4ϩ cells were diluted into fresh medium, a marked delay in the re-entry of the csk1::URA4ϩ strain into the cell cycle was observed ( Figure 1G ). This could reflect a delay in the re-activation of the inactive and unphosphorylated Cdc2 kinase characteristic of stationary phase (Simanis and Nurse, 1986) .
Regulation of Mcs6-Mcs2 kinase activity in vivo by Csk1
The genetic interactions between csk1, mcs6 and mcs2 suggested that Csk1 may regulate the Mcs6-Mcs2 complex. Indeed, in a previous study, the Mcs2-associated kinase activity was found to decrease 3-fold in a csk1 deletion strain (csk1::sup3-5) when compared with a wildtype strain using myelin basic protein (MBP) as a substrate (Molz and Beach, 1993) . In that study, strains where the endogenous mcs2 was replaced with an allele encoding a hemagglutinin (HA)-tagged Mcs2 (Molz and Beach, 1993) were used. Subsequently, Mcs6 was identified as the Mcs2-associated kinase, new substrates were identified (Buck et al., 1995; Damagnez et al., 1995) and the specific activity of Mcs6-Mcs2 toward the RNA Pol II CTD was found to be several orders of magnitude higher than toward MBP (data not shown). Therefore, using the strategy described above, the CTD kinase activity of Mcs6-Mcs2 in a wild-type strain (with Mcs2-HA) and in an isogenic strain with a csk1 disruption were compared The potential genetic interaction of csk1 and mcs6 was tested by crossing mcs6-13 with a csk1 disruptant strain csk1::sup3-5. In order to analyse the phenotypes, all three mutant strains have been streaked on YES media at either 30 or 37°C (A). Separately, cells from the mcs6-13 csk1::sup3-5 strain (B and C) or the same strain transformed with csk1-pREP3 (D) were fixed with glutaraldehyde and stained with DAPI and calcofluor. The cells analysed in (B) were grown at 30°C; the cells in (C) and (D) were analysed 20 h after a shift to 37°C. To analyse further the csk1 disruption phenotype, a csk1::URA4ϩ strain was grown in YES (E) or EMM minimal media (F), and cells were stained with DAPI and calcofluor. Growth rates of the strain on YES and EMM were measured after inoculation from a culture arrested in stationary phase (G).
Fig. 2. Mcs2-associated CTD kinase activity is regulated in vivo by
Csk1. To analyse Mcs2-associated kinase activity, Mcs2 was immunoprecipitated from S.pombe cells with an integrated mcs2-HA allele (wt) or an isogenic strain with a csk1 disruption (Δ) using 12CA5 anti-HA monoclonal antibodies. The activity of the kinase toward a triple-CTD peptide was tested in an in vitro kinase reaction followed by SDS-PAGE and autoradiography.
( Figure 2) . A 3-fold decrease in CTD activity in the csk1 disruption strain indicates that Csk1 regulates Mcs6-Mcs2 in vivo, and is in agreement with previous results with MBP (Molz and Beach, 1993) .
Csk1 phosphorylates Mcs6 on the potential CDK activation site S165
The genetic interactions of csk1 with mcs6 and mcs2 and the regulation of Mcs6-S165A proteins were tested as substrates for the Csk1 kinase. Mcs6 or Mcs6-S165A were purified from S.pombe cells overexpressing the corresponding myc-tagged proteins using 9E10 anti-myc monoclonal antibodies. Csk1 was purified from S.pombe cells overexpressing HA-tagged Csk1 using 12CA5 anti-HA monoclonal antibodies. The lanes without Csk1 contained a control purification from cells not expressing HA-tagged Csk1. Following a kinase reaction, products were analysed by SDS-PAGE, transferred to a nitrocellulose membrane and subjected to autoradiography. Bottom panel: the nitrocellulose membrane was used for Western blotting analysis with the 9E10 anti-myc monoclonal antibodies to visualize the myc-tagged Mcs6 or Mcs6-S165A proteins.
phorylate Mcs6 ( Figure 4A ). In this case, the Mcs6 was purified from insect cells co-infected with mcs6 and mcs2 baculoviruses using anti-Mcs6 antiserum, and therefore contains Mcs6 complexed with Mcs2 (see below). As demonstrated in the right lane in Figure 4A , Mcs6 is phosphorylated efficiently by the recombinant GST-Csk1 in these conditions. In parallel experiments, GST-Csk1 was also found to phosphorylate a human CDK7 (complexed with cyclin H; Figure 4B ) and GST-CDK2 ( Figure  4C ), but not an RNA Pol II CTD substrate ( Figure 4D ). These results indicate that Csk1 phosphorylates Mcs6 and other CDKs as a single subunit kinase. As with Mcs6 (see above), the Csk1-mediated CDK2 phosphorylation was on the T-loop activation site T160 ( Figure 4C ), and was found to activate a CDK2-cyclin A complex ( Figure 4E) . A bacterially produced GST-Csk1 also retains CDKphosphorylating activity (data not shown), indicating that Csk1 does not require kinases or binding partners to be active.
Csk1 is a CDK-activating kinase for Mcs6-Mcs2
As shown in Figure 3 , Csk1 phosphorylates Mcs6 on the apparent CDK activation site. To investigate whether this phosphorylation indeed activates the Mcs6-Mcs2 complex, insect cells were infected with mcs6 or mcs2, or double-infected with both mcs6 and mcs2. The corresponding proteins were then immunopurified with either anti-Mcs2 or anti-Mcs6 antisera and tested in a Csk1 activation assay ( Figure 5A ). The assay consisted of an initial kinase reaction where the mcs2 or mcs6 immunoprecipitates were incubated with unlabelled ATP and either GST-Csk1 or GST. Subsequently, GST-Csk1 or GST were removed with three washes, and the remaining Mcs2 or Mcs6 complexes were tested for either GST-CTD or GST-CDK2 activity. In anti-Mcs2 complexes, activity was only detected in the Mcs6-Mcs2 co-infection, and this activity was significantly increased by Csk1 activation ( Figure 5A, top panel) . Similarly, anti-Mcs6 complexes had activity in the Mcs6-Mcs2 co-infection, and an 
Csk1 phosphorylates and activates cyclin-free Mcs6
In addition to phosphorylating and activating Mcs6 complexed to Mcs2, Mcs6 purified from the mcs6 single infections was active toward both GST-CTD and GST-CDK2, The cyclin-free Mcs6 was strongly dependent on Csk1 activation in vitro (see above). To analyse the effect of Csk1 on cyclin-free Mcs6 in S.pombe cells, a myc-tagged Mcs6 was overexpressed using the strong nmt1 promoter in S.pombe cells with a csk1 disruption (Δ), wild-type csk1 (wt) or overexpressed csk1 (ϩϩ; Figure 6 ). Subsequently, anti-myc immunoprecipitates from these strains were analysed for CTD kinase activity ( Figure 6A ). In the cells with wild-type csk1, the CTD kinase activity was clearly higher than that seen previously for endogenous Mcs2 (see Figure 2) , and thus shorter exposures are shown. The stronger activity is likely to reflect cyclin-free Mcs6 activity. Moreover, the regulation of the myc-Mcs6 activity by Csk1 is very pronounced; the activity in the disruptant is Ͼ30-fold decreased compared with wild-type, and the activity in the overexpression strain is 10-fold increased as determined by quantitation of incorporated radioactivity.
Western blotting analysis of myc-Mcs6 from total lys- ates from the strain wild-type for csk1 ( Figure 6B ) indicates that myc-Mcs6 is a doublet as previously reported (Damagnez et al., 1995) , although the separation of the two bands is somewhat dependent on gel running conditions (see, for example, Figure 3) . A similar pattern is seen with several other CDKs, e.g. CDK7 (Martinez et al., 1997) , where the faster migrating band represents CDK7 phosphorylated in the T-loop activation site. Accordingly, in Mcs6, the faster migrating band represents S165-phosphorylated Mcs6 based on the migration of the Mcs6-S165A mutant (Figures 3 and 7) . In the csk1 disruptant, only the unphosphorylated form is detectable. On the contrary, myc-Mcs6 in the Csk1-overexpressing lysate is mostly phosphorylated. These data indicate that Csk1 is the major if not only kinase phosphorylating Mcs6 on S165 in vivo. Another interesting observation from this experiment is that the level of the overexpressed Mcs6 in the lysates is inversely correlated with Csk1 levels, suggesting that the phosphorylated overexpressed Mcs6 is targeted for degradation. Despite the lower levels of Mcs6 in the Csk1-overexpressing strain, the amounts of Mcs2 associated were similar ( Figure 6C ), indicating that only a subset of Mcs6 is associated with Mcs2. This is not surprising, as the Mcs6 is overexpressed from the strong nmt1 promoter, and thus the endogenous levels of Mcs2 are likely to be limiting.
Phosphorylation on the conserved CAK site of Mcs6 is not required to form a functional Mcs6-Mcs2 complex in vivo
Schizosaccharomyces pombe cells with a csk1 disruption grow poorly on minimal media ( Figure 7A ). Mcs6 over-
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Fig. 7.
Mcs6-S165A can associate with Mcs2 in vivo to form a functional complex. To test the ability of the Mcs6-S165A mutant to complement the growth retardation of a csk1::ura4ϩ mutant (A), growth rates of csk1 disruptant strains transformed with either myc epitope-tagged mcs6-pREP3 (B) or the mcs6 S165A-pREP3 (C) were measured. (D) Anti-myc immunoprecipitates from strains with the mcs6-pREP3 or mcs6 S165A-pREP3 plasmids and an HA-tagged integrated mcs2 were analysed for the presence of mcs2 with an anti-HA Western blot (upper panel). The levels of immunoprecipitated mycMcs6 or myc-Mcs6-S165A were then controlled using an anti-Myc Western blot (bottom panel). (E) The CTD kinase activity associated with myc-Mcs6-S165A in the strain described above or associated with myc-Mcs6 in a Csk1::ura4ϩ strain with myc-epitope tagged mcs6-pREP3 was measured in an in vitro kinase as described in Figure 2 .
expression in this strain rescued this growth retardation phenotype completely ( Figure 7B ). This suggests that Mcs6 phosphorylation on S165 is not required when Mcs6 is overexpressed. Accordingly, the Mcs6-S165A mutant was indistinguishable from Mcs6 in rescuing the csk1 disruption phenotype ( Figure 7C ), and indeed the S165A mutant of Mcs6 also rescued the synthetic lethality of the mcs6-13 csk1::sup3-5 strain (data not shown). The rescue by Mcs6-S165A presumably resulted from an active Mcs6-S165A-Mcs2 complex. To investigate the relative activities of Mcs6 and Mcs6-S165A, these proteins were expressed in S.pombe cells with a wild-type Csk1 to enable Mcs6 to become phosphorylated. As shown in Figure 7D , Mcs2 associated with both wild-type and mutant Mcs6 in a similar fashion. The kinase activity of the overexpressed Mcs6-S165A was low but detectable ( Figure 7E ), and indeed comparable with the kinase activity of overexpressed Mcs6 from the Csk1 disruptant ( Figure 7E ; a 30 h exposure is shown compared with the 3 h exposure in Figure 6A ).
In conclusion, the characteristics of Mcs6-S165A in vivo are in agreement with several biochemical observations made with the apparent functional homologue CDK7 (Devault et al., 1995; Fisher et al., 1995; Martinez et al., 1997) . Taken together, these results suggest that with either Mcs6 or CDK7, phosphorylation on the conserved CAK site is not required for cyclin binding or for activity. In CDK7, the alternative activation mechanism involves the assembly factor MAT1, and an analogous mechanism may exist in S.pombe. 
Csk1 kinase activity is constant throughout the cell cycle
The total levels of Mcs2 and the activity of the Mcs2-associated kinase (presumably Mcs6) are constant throughout the cell cycle (Molz and Beach, 1993) , which may not be surprising if this complex is involved in both CDK activation and RNA polymerase II CTD phosphorylation. To study Csk1 activity during the cell cycle, we analysed the kinase activity associated with a specific ( Figure 8A ) polyclonal Csk1 antiserum from lysates of synchronized ( Figure 8B ) cdc25-22 cells ( Figure 8C ). As a control for the synchrony, histone H1 kinase activity from full lysates was performed from parallel samples ( Figure 8C ), demonstrating a first peak at 20 min following the temperature shift, indicating that the cells were entering mitosis from the arrest in G 2 . No significant differences in the activity of Csk1 was observed at any point during the first cell cycle and up to the second mitosis (at 180 min). As neither Mcs6-Mcs2 (Molz and Beach, 1993) nor Csk1 activities are cell cycle regulated, the CAK phosphorylation on cdc2 may be a required, but not a regulated modification. In this light, it is quite surprising to identify an elaborate cascade of kinases fulfilling this function, and it may be that this pathway could be used in a regulatory fashion in, for example, response to stress or nutritional and environmental conditions.
Discussion
The S.pombe csk1 gene was identified originally as a multicopy suppressor of a mutant allele of the mcs2 cyclin, and was suggested to encode the catalytic subunit of Mcs2 (Molz and Beach, 1993) . Later, Mcs6 (originally termed Mop1/Crk1) was identified as the CDK partner of Mcs2, implying another function for Csk1. In this study, the functional basis for the observed genetic interaction of csk1 with mcs2 was investigated.
Initially, the genetic interaction of csk1 with mcs2 was extended to include mcs6. A synthetic lethal interaction between csk1 disruption and mcs6-13 was identified, with a terminal phenotype reminiscent of that seen with either mcs6 or mcs2 disruptions. The terminal phenotype includes highly elongated cells with multiple septa and fragmented nuclei. However, the multiple septa phenotype only appears after 18 h although the growth arrest following the temperature shift is very rapid and is accompanied by fragmented nuclei. Interestingly, the synthetic lethality was rescued not only by Csk1 or Mcs6 overexpression, but also by overexpression of the S.cerevisiae Cak1/Civ1 (T.Westerling, A.Pihlak, D.Hermand, J.-Y.Thuret, C.Mann and T.P.Mäkelä, in preparation). In contrast, the growth retardation phenotype in the csk1 disruptant strain was rescued by Mcs6 overexpression, but not by Cak1/Civ1 overexpression (T.Westerling, A.Pihlak, D.Hermand, J.-Y.Thuret, C.Mann and T.P. Mäkelä, in preparation) . This suggests that the csk1 disruptant phenotype is due mainly to inefficient activation of Mcs6, indicating that phosphorylation of Mcs6 on the CAK site is not essential, but clearly beneficial for Mcs6, and that Csk1 is likely to be the major kinase phosphorylating Mcs6 in vivo.
Although csk1 is not an essential gene, it is clearly implicated in the control of cell growth. A csk1 disruptant is sensitive to medium composition, and the strain is defective in re-growth from stationary phase and presents a growth retardation. However, the only clear phenotype of the csk1 disruptant with aberrant calcofluor staining of cell wall material at the ends of the cells is difficult to interpret with current knowledge, and could be either cell cycle or transcription related.
Mcs2-associated kinase activity was decreased 3-fold in a csk1 disruptant strain both toward the originally used substrate MBP (Molz and Beach, 1993) and the RNA polymerase II CTD substrate (this study), establishing a functional link between Csk1 and the Mcs6-Mcs2 complex. When using recombinant proteins, Csk1 was found to activate the Mcs6-Mcs2 complex toward both RNA Pol II CTD and GST-CDK2. These results identify the fission yeast Csk1 kinase as an in vivo activating kinase of the Mcs6-Mcs2 CAK, defining Csk1 as a CAKAK. Whether similar kinases exist in other species remains to be studied, but it is interesting to note that Csk1 phosphorylated and activated a CDK7-cyclin H complex in conditions where no activation by GST-CDK2-cyclin A was observed (Figure 4 , and data not shown).
The Mcs6 homologue CDK7 is phosphorylated on two sites in the T-loop. Phosphorylation of T170 (T176 in Xenopus) enhances association (Fisher and Morgan, 1994; Mäkelä et al., 1994) and activity (Labbe et al., 1994) of CDK7-cyclin H, and this site corresponds to the conserved activation site of CDKs (CAK site). The role of S164 (S170 in Xenopus) phosphorylation is less clear (Poon et al., 1994; Fisher et al., 1995; Martinez et al., 1997 ; see also below). Both of these sites can be phosphorylated by CDK2-cyclin A and cdc2-cyclin B in vitro (Fisher et al., 7236 1995; Martinez et al., 1997) , and indeed, based on the ability of these kinases to activate CDK7-cyclin H, they were defined as CAKAKs . In this regard, in vivo CAKAK Csk1 was distinct in that it was found to phosphorylate Mcs6 only on the conserved CAK site (S165), suggesting that if the site corresponding to CDK7 S164 (T160 in Mcs6) is phosphorylated in vivo, it is mediated by a distinct kinase (see also below).
Phosphorylation of the CAKAK site of Mcs6 in vivo is not essential, as Mcs6-S165A rescued the synthetic lethality of mcs6-13 csk1::sup3-5. The mammalian CDK7-cyclin H complex can be activated in vitro either by phosphorylation on the CAKAK site or by associating with MAT1. The contributions of these alternative (but not exclusive) activation mechanisms in vivo is not clear. It is interesting to speculate that the rescue by Mcs6-S165A is based on a MAT1 homologue in S.pombe cells. A MAT1 homologue in S.pombe could also be important in determining the substrate specificity of the Mcs6 kinase, as has been identified in other systems (Inamoto et al., 1997; Ko et al., 1997; Rossignol et al., 1997; Yankulov and Bentley, 1997) .
In contrast to the general dogma of a CDK being dependent for catalytic activity on its cognate cyclin subunit, a baculovirus-expressed Mcs6 kinase can be phosphorylated and activated directly by Csk1. Both the activity and tight regulation by CAKAK site phosphorylation of monomeric Mcs6 is similar to activities described for in vitro translated Xenopus CDK7 (Martinez et al., 1997) . More importantly, when Mcs6 is overexpressed from the strong nmt-1 promoter in fission yeast cells, the kinase activity associated with the overexpressed Mcs6 is significantly higher and more tightly under Csk1 regulation than activity associated with endogenous Mcs6-Mcs2 complexes (Figures 2 and 6 ). This suggests that the Mcs6 can act as a monomer in vivo, although as of yet there is no evidence for a physiological role for such a kinase.
The ability of Csk1 to phosphorylate Mcs6 in the absence of the Mcs2 cyclin is reminiscent of what is seen with another single subunit CAK: the budding yeast Cak1/ Civ1 kinase, which phosphorylates CDC28 before cyclin binding (Espinoza et al., 1996; Kaldis et al., 1996 Kaldis et al., , 1998 Thuret et al., 1996) . In this regard, it is interesting to point out that although Cak1/Civ1 and Csk1 are only distantly related in primary structure, they share several features not common in serine-threonine kinases. Moreover, Csk1 is able to complement a temperature-sensitive mutant of Cak1/Civ1 in budding yeast, indicating that in these conditions, Csk1 is in fact an in vivo CAK of CDC28 (T.Westerling, A.Pihlak, D.Hermand, J.-Y.Thuret, C.Mann and T.P. Mäkelä, in preparation) . Taken together with the capacity of Csk1 to activate other CDKs (Figure 4) , it is tempting to speculate that perhaps Csk1 could also function as a CAK for cdc2. These questions will be interesting to study when reagents become available. However, the current results unambiguously indicate that fission yeast has at least two CAKs: Csk1 that activates Mcs6, and another CAK (the only candidate being Mcs6-Mcs2) responsible for the essential cdc2 activation, and present in the viable Csk1 disruptant strain.
Materials and methods
Yeast strains and techniques
The S.pombe strains used in this study were: h ϩN ade6-216 leu1-32 ura4D18, h ϩ mcs2::mcs2F leu1-32 ura4D18 ade6, h ϩ csk1::sup3-5 leu1-32 ade6-704 Beach, 1993), h -mcs6-13 leu1-32 ura4D18 ade6 (Molz et al., 1989) and h -cdc25-22 leu1-32 ura4-D18 ade6-216, hcsk1::sup3-5 mcs6-13 leu1-32 ade6-704, h ϩ csk1::ura4ϩ mcs2::mcs2F leu1-32 ura4D18 ade6 . The S.pombe were transformed using the lithium acetate high efficiency transformation protocol (Moreno et al., 1991) . Genetic crosses, synchronization using the cdc25-22 block-release protocol and analysis were performed according to Moreno et al. (1991) .
Cloning of csk1
The csk1 open reading frame (ORF) was amplified from a S.pombe cDNA library (a kind gift from Drs Michelle Minet and Francois Lacroute) using the CF1 (5Ј-GGG-GAA-TTC-AAT-TTA-ATG-AAA-TCA-GTC-3Ј) and CR1 (5Ј-TCT-CTC-TCG-AGT-TAT-GCA-TAT-TGT-GAA-AGC-C-3Ј) primers. The EcoRI-XhoI-digested PCR product was introduced into the pGEX-4T bacterial expression vector (Pharmacia) and confirmed by sequencing.
Schizosaccharomyces pombe expression vectors
The csk1 ORF described above was introduced into the S.pombe expression vectors pAHA [a modified pAAUN (Xu et al., 1990) with an N-terminal HA epitope tag] and into pREP3 (Maundrell, 1993) . mycmop1-pREP-3 was described previously (Damagnez et al., 1995) . The S165A mutant of mcs6 (or mop1) was made by replacing the insert in myc-mop1-pREP-3-by a two-step PCR approach using pREP-3-mycmop1 as the template. In the first step, the 5Ј PCR fragment was made with primers MopS165A1, 5Ј-AGC-GGC-CGC-GTC-GAC-ACC-ATG-GAA-CAG-3Ј, and MopS165A2, 5Ј-C-CTG-ATG-AGC-CAT-ATG-GCT-TGG-G-3Ј, where Ser165 was mutated to alanine with the introduction of a silent NdeI restriction site (underlined). The 3Ј PCR fragment was made with primers MopS165A3, 5Ј-C-CCA-AGC-CAT-ATG-GCT-CAT-CAG-G-3Ј, where Ser165 was mutated to alanine with the introduction of a NdeI restriction site (underlined), and MopS165A4, 5Ј-TGC-GGC-CGC-GGA-TCC-TTA-AAC-AAA-TT-3Ј. The second PCR was made with MopS165A1 and MopS165A4 using the described PCR fragments as template. Sequencing checked the full-length sequence of the mutant.
Disruption of csk1
A 300 bp internal HindIII fragment from csk1 was replaced by the URA4ϩ cassette from pAAUN (Xu et al., 1990) . Subsequently, the 2.5 kb EcoRI-XhoI insert containing the URA4ϩ marker was used to transform the S.pombe strain h ϩ mcs2::mcs2F leu1-32 ura4D18 ade6. The correct integration was confirmed by PCR followed by a Southern blot.
Csk1, Mcs6 and Mcs2 antibodies
C-terminal 15 amino acid peptides from Csk1 (IESFPKVSARLSQYA) or Msc6 (QRQNNFPMRANIKFV) were synthesized, linked to keyhole limpet hemocyanin (KLH), and used for immunization of rabbits.
The resulting polyclonal antisera were tested for specificity using the recombinant baculoviruses and S.pombe strains overexpressing the corresponding proteins with epitope tags by Western blots and immunoprecipitation. The Mcs2 rabbit polyclonal antiserum was generated against a full-length Mcs2 protein, and was a kind gift from Drs Eberhard Schneider and Peter Wagner (unpublished).
Generation of baculoviruses
The GST-Csk1-expressing baculovirus was made by inserting the csk1 ORF as a EcoRI-NotI fragment from pGEX-4T-csk1 into pAcGHLT-A (Pharmingen) transfer vector, which was introduced into Sf9 insect cells together with BaculoGold (Pharmingen) baculovirus DNA as recommended by the manufacturer. An empty pAcGHLT was used to make a control GST-expressing virus. The mcs2 and mcs6 viruses were made by inserting the ORF of the respective genes into the pVL1392 (Pharmingen) transfer vector following the protocol above. The cyclin H virus was generated by inserting a BamHI-XbaI fragment containing the ORF of human cyclin H into BglII-XbaI of the pEV55 transfer vector. The HA epitope-tagged CDK7 virus (Fisher and Morgan, 1994) was a kind gift from Robert Fisher and David Morgan.
Protein expression, purifications and immunoprecipitations
For protein expression, the baculoviruses were propagated in Hi5 insect cells (Invitrogen) for 48 h. The GST-Csk1 and GST proteins were purified using glutathione-Sepharose and eluted with glutathione. About 10 ng of purified protein was used per assay. Mcs6, Mcs2 and Mcs6-Mcs2 complexes were purified with specific antisera as indicated and used still bound to protein A-Sepharose. The HA-CDK7-cyclin H 7237 complex was immunopurified with HA 12CA5 mouse monoclonal antibody (Boehringer Mannheim, Germany).
Bacterially expressed GST-CDK2-D155N, GST-CDK2-T160A and GST-CTD (a kind gift from David Chao and Richard Young) proteins were purified using glutathione-Sepharose beads (Damagnez et al., 1995) . The CTD peptide was a triple repeat of the RNA polymerase II CTD motif linked to biotin (YSPTSPSYSPTSPSYSPTSPS-biotin).
Production of Csk1 in rabbit reticulocyte lysate using T7 RNA polymerase was performed according to the manufacturer's instructions (Promega, TNT kit).
For immunoprecipitations from S.pombe cells, yeast strains (10 ml) were grown overnight in selective media. Subsequently, cell pellets were washed once in phosphate-buffered saline, and disrupted in lysis buffer [150 mM NaCl, 50 mM HEPES pH 7.5, 5 mM EDTA, 1% NP-40 with 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM β-glycerophosphate and 5 mM NaF]. Following disruption, lysates were adjusted to 0.5% NP-40 for immunoprecipitation with the HA antibody (Boehringer Mannheim), the myc 9E10 mouse monoclonal antibody (Babco Inc., Berkeley, CA) or other antisera. Immunoprecipitates on protein ASepharose (Sigma) beads were washed four times with lysis buffer containing 0.1% NP-40, and once with kinase buffer [20 mM Tris pH 7.5, 50 mM KCl, 5 mM MgCl 2 , 2.5 mM MnCl 2 , 1 mM dithiotreitol (DTT)].
Kinase assays and Western blotting
For standard kinase reactions, 10 ng of GST-Csk1, 100 ng of Mcs6-Mcs2, 100 ng of HA-CDK7 or immunoprecipitates as indicated were used as kinases. Kinase reactions were performed in 30 μl of kinase buffer supplemented with 10 μCi of [γ-32 P]ATP and the indicated substrates (2 μg of CTD peptide, 4 μg of GST-CDK2-D155N, 4 μg of GST-CDK2-D155N-T160A, 4 μg of GST-CTD) for 30 min at 30°C.
For the initial kinase reaction of the CAK assay presented in Figure  4E , 500 ng of cyclin A [a kind gift of Jean-Yves Thuret and Carl Mann (Thuret et al., 1996) ] and 5 μl of a reticulocyte lysate programmed with csk1 (or unprogrammed as control) were incubated with CDK2 immunopurified (M2, Santa Cruz Biotechnology) from rabbit reticulocyte lysate in kinase buffer supplemented with 1 mM cold ATP for 10 min at 30°C. The CDK2 still bound on beads was purified by three washes followed by a kinase reaction with 10 μCi of [γ-32 P]ATP and 4 μg of histone H1 as a substrate.
In the CDK activation experiments in Figure 5A , GST-Csk1 was incubated with Mcs6, Mcs2 or Mcs6-Mcs2 bound to beads for 6 min at 30°C in kinase buffer supplemented with 100 μM ATP. Subsequently, the beads were washed three times with kinase buffer before a kinase reaction with [γ-32 P]ATP with GST-CTD or GST-CDK2 substrates. Phosphorylated substrates were analysed by 10% SDS-PAGE followed by autoradiography. Western blotting analysis was according to standard procedures.
